Legend Biotech Corp Adr (LEGN)

Jul 28, 2026

H.C. Wainwright reiterates Buy on Legend Biotech stock, $65 target - Investing.com

Jul 28, 2026

Jul 27, 2026

Raymond James cuts Legend Biotech stock price target on CEO departure - Investing.com

Jul 27, 2026

Jul 27, 2026

Why is Legend Biotech stock sliding today? By Investing.com - Investing.com South Africa

Jul 27, 2026

Jul 27, 2026

Why is Legend Biotech stock sliding today? - Investing.com

Jul 27, 2026

Jul 27, 2026

Legend Biotech stock falls as CEO Ying Huang steps down By Investing.com - Investing.com South Africa

Jul 27, 2026

Jul 27, 2026

Legend Biotech stock falls as CEO Ying Huang steps down - Investing.com

Jul 27, 2026

Jul 27, 2026

Legend Biotech CEO Ying Huang steps down, Alan Bash named interim By Investing.com - Investing.com South Africa

Jul 27, 2026

Jul 27, 2026

Legend Biotech CEO Ying Huang steps down, Alan Bash named interim - Investing.com

Jul 27, 2026

Jul 24, 2026

UBS downgrades Legend Biotech stock rating on competition concerns - Investing.com

Jul 24, 2026

Jul 24, 2026

UBS downgrades Legend Biotech stock rating on competition concerns By Investing.com - Investing.com India

Jul 24, 2026

Jul 16, 2026

Analysts Offer Insights on Healthcare Companies: Medicinova (MNOV), Legend Biotech (LEGN) and AngioDynamics (ANGO) - The Globe and Mail

Jul 16, 2026

Jul 16, 2026

H.C. Wainwright reiterates Legend Biotech stock rating on strong Carvykti sales - Investing.com

Jul 16, 2026

Jul 13, 2026

JPMorgan resumes Legend Biotech stock coverage with neutral rating By Investing.com - Investing.com South Africa

Jul 13, 2026

Jul 13, 2026

JPMorgan resumes Legend Biotech stock coverage with neutral rating - Investing.com

Jul 13, 2026

Jul 10, 2026

Legend Biotech (LEGN) Short Interest & Short Float | Updated Jul 2026 - MarketBeat

Jul 10, 2026

Jul 04, 2026

LEGNLegend Biotech Corp ADR Options - Finviz

Jul 04, 2026

Jul 02, 2026

Legend Biotech (LEGN) CEO Ying Huang makes charitable gift of 3,382 shares - Stock Titan

Jul 02, 2026

Jun 30, 2026

Form 144 Legend Biotech Corp For: 30 June By Investing.com - Investing.com India

Jun 30, 2026

Jun 30, 2026

Form 4 Legend Biotech Corp For: 29 June - Investing.com India

Jun 30, 2026

Jun 29, 2026

Legend Biotech CEO Huang Ying sells $82,265 in shares By Investing.com - Investing.com South Africa

Jun 29, 2026

Jun 29, 2026

Form 4 Legend Biotech Corp For: 29 June By Investing.com - Investing.com South Africa

Jun 29, 2026

Jun 29, 2026

Legend Biotech CEO Huang Ying sells $82,265 in shares - Investing.com

Jun 29, 2026

Jun 26, 2026

Form 144 Legend Biotech Corp For: 26 June By Investing.com - Investing.com South Africa

Jun 26, 2026

Jun 26, 2026

Legend Biotech (LEGN) 10K Form and Latest SEC Filings 2026 - MarketBeat

Jun 26, 2026

Jun 26, 2026

Legend Biotech Corp. Sponsored ADR Actuals & Estimates (NASDAQ:LEGN) - TradingView

Jun 26, 2026

Jun 25, 2026

9LB Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026

Jun 24, 2026

After Apogee, 3 More Biotech Buyout Targets Wall Street Can’t Stop Watching - AOL.com

Jun 24, 2026

Jun 22, 2026

Form 6K Legend Biotech Corp For: 22 June By Investing.com - Investing.com South Africa

Jun 22, 2026

Jun 18, 2026

Form 424B5 Legend Biotech Corp - StreetInsider

Jun 18, 2026

Jun 18, 2026

Legend Biotech (LEGN) raises ~$211.6M selling 7.7M ADSs; option for 1.155M more - Stock Titan

Jun 18, 2026

Jun 18, 2026

symbol__ Stock Quote Price and Forecast - CNN

Jun 18, 2026

Jun 18, 2026

Why Is Legend Biotech Stock Falling Thursday? - Benzinga

Jun 18, 2026

Jun 17, 2026

Legend Biotech prices $226 million public offering at $29.35 By Investing.com - Investing.com South Africa

Jun 17, 2026

Jun 17, 2026

Legend Biotech prices $226 million public offering at $29.35 - Investing.com

Jun 17, 2026

Jun 17, 2026

Legend Biotech launches $225 million public share offering - Investing.com

Jun 17, 2026

Jun 17, 2026

Legend Biotech stock falls on $225M share offering plan - Investing.com

Jun 17, 2026

Jun 17, 2026

Legend Biotech (NASDAQ: LEGN) files $225M ADS offering to fund pipeline - Stock Titan

Jun 17, 2026

Jun 17, 2026

Legend Biotech stock falls on $225M share offering plan By Investing.com - Investing.com India

Jun 17, 2026

Jun 15, 2026

Legend Biotech reports early trial success for in vivo CAR-T therapy - Investing.com

Jun 15, 2026

Jun 15, 2026

Legend Biotech reports early trial success for in vivo CAR-T therapy By Investing.com - Investing.com South Africa

Jun 15, 2026

Jun 03, 2026

UBS raises Legend Biotech stock price target on NHL therapy outlook By Investing.com - Investing.com South Africa

Jun 03, 2026

Jun 03, 2026

UBS raises Legend Biotech stock price target on NHL therapy outlook - Investing.com

Jun 03, 2026

Jun 02, 2026

GENSCRIPT BIO Spikes 19% as Legend Biotech Corporation (LEGN.US) Announces Positive Prelim Clinical Data for Lymphoma Therapy - aastocks.com

Jun 02, 2026

Jun 02, 2026

Cancer Drug Proves 100% Successful In Early Study; What's Next? - Investor's Business Daily

Jun 02, 2026

Jun 02, 2026

Keep an eye on the top gainers and losers in Tuesday's session. - ChartMill

Jun 02, 2026

Jun 02, 2026

Legend Biotech reports phase 1 data for in vivo CAR-T therapy - Investing.com

Jun 02, 2026

Jun 01, 2026

RBC Capital reiterates Legend Biotech stock rating at Outperform By Investing.com - Investing.com South Africa

Jun 01, 2026

Jun 01, 2026

RBC Capital reiterates Legend Biotech stock rating at Outperform - Investing.com

Jun 01, 2026

Jun 01, 2026

H.C. Wainwright reiterates Legend Biotech stock rating at buy - Investing.com

Jun 01, 2026

May 31, 2026

Legend Biotech Conference Spotlights CARVYKTI’s Curative Potential, Earlier Use - Yahoo Finance

May 31, 2026

May 27, 2026

H.C. Wainwright reiterates Legend Biotech stock rating at buy By Investing.com - Investing.com South Africa

May 27, 2026